Fulvestrant/Anastrozole in Metastatic Breast Cancer - The ASCO Post - fulvestrant breast


Fulvestrant - a novel endocrine therapy for breast cancer. fulvestrant breast

Breast cancer in post-menopausal women, that has spread to other areas such as the lymph nodes, can be treated using fulvestrant (also known as Faslodex).

Fulvestrant is a novel endocrine therapy for breast cancer, with a unique structure and mode of action. It binds competitively to the oestrogen receptor (ER), with.

Whether taken alone or in combination, FASLODEX acts on the estrogen receptor in hormone receptor positive metastatic breast cancer.